Several common medications can raise uric acid levels in your blood and trigger gout flare-ups. Diuretics (water pills) are the most well-known culprits, but the list extends to certain blood pressure drugs, low-dose aspirin, anti-rejection drugs for transplant patients, tuberculosis treatments, and even some vitamins. Knowing which medications carry this risk can help you and your doctor choose alternatives that keep your joints calm.
Diuretics: The Most Common Trigger
Diuretics are the medication class most strongly linked to gout. They work by pushing your kidneys to excrete more water and salt, but in the process, they also cause your kidneys to hold onto uric acid. Specifically, diuretics increase uric acid reabsorption and decrease uric acid secretion in the kidney, and the effect gets worse at higher doses.
Both thiazide diuretics (like hydrochlorothiazide, commonly prescribed for high blood pressure) and loop diuretics (like furosemide, often used for heart failure) carry this risk. In a large population study published in The BMJ, current diuretic use more than doubled the risk of developing gout compared to other blood pressure treatments, with a relative risk of 2.36. If you have gout and take a diuretic for blood pressure, current guidelines from the American College of Rheumatology recommend switching from hydrochlorothiazide to losartan when possible.
Other Blood Pressure Medications
Diuretics aren’t the only blood pressure drugs that raise gout risk. Beta blockers increase the risk by about 48%, and ACE inhibitors raise it by roughly 24%. Even most angiotensin II receptor blockers (ARBs) are associated with a 29% increased risk. These effects were found after accounting for other gout risk factors like weight and alcohol use.
There is one notable exception: losartan. Unlike other ARBs, losartan actually lowers uric acid levels by 20 to 25% through a uric acid-flushing effect in the kidneys. Over two or more years of use, losartan was associated with a 29% lower risk of developing gout. Calcium channel blockers (like amlodipine and nifedipine) also appear protective, reducing gout risk by 13 to 21% depending on the specific drug, with greater benefit the longer you take them.
Low-Dose Aspirin
Aspirin has a quirky, dose-dependent relationship with uric acid. At low doses (the 75 to 325 mg range many people take daily for heart protection), aspirin slows uric acid excretion by about 15%, which nudges blood levels up enough to potentially trigger flares in someone already prone to gout. At very high doses above 3 grams per day (the kind once used for arthritis), aspirin actually flushes uric acid out. Nobody takes aspirin at those high doses anymore, so in practice, aspirin use almost always means a slight increase in uric acid.
Despite this, the ACR recommends continuing low-dose aspirin if you need it for heart disease prevention. The cardiovascular benefit outweighs the modest bump in gout risk, and your doctor can manage uric acid through other means.
Anti-Rejection Drugs After Organ Transplant
Cyclosporine, an immunosuppressant commonly used after organ transplants, is one of the strongest medication-related gout triggers. Among solid organ transplant patients taking cyclosporine, 18.3% had gout, roughly double the rate seen in transplant patients taking tacrolimus (9.3%) or neither drug (9.1%). Cyclosporine interferes with uric acid clearance in the kidneys while also reducing kidney function overall, creating a one-two punch that makes gout common in this population.
Tacrolimus carries some risk as well, though clearly less than cyclosporine. If you’ve had a transplant and develop gout, your transplant team may consider adjusting your immunosuppression regimen, though the decision involves balancing gout management against organ rejection risk.
Tuberculosis Medications
Pyrazinamide, a standard part of tuberculosis treatment, is one of the most potent uric acid-raising drugs in clinical use. At just 300 mg per day, it can reduce the kidney’s ability to clear uric acid by up to 80%. It works by converting into a byproduct called pyrazinoic acid, which nearly shuts down the kidney’s normal pathway for secreting uric acid while also increasing reabsorption of uric acid that was already filtered out.
Ethambutol, another tuberculosis drug, raises uric acid through a similar mechanism. Patients on standard TB treatment may develop joint symptoms within weeks. In one documented case, a patient developed redness, pain, and swelling in the knee after eight weeks of therapy. Because TB treatment typically lasts six to nine months and can’t be easily stopped, managing gout flares alongside TB requires careful coordination.
Chemotherapy and Cancer Treatment
Cancer treatments that rapidly kill large numbers of cells can flood the bloodstream with uric acid in a process called tumor lysis syndrome. When cells break apart, their DNA and RNA get broken down into uric acid. If enough cells die at once, the kidneys can’t keep up, and uric acid levels spike dramatically.
This is most common with blood cancers that involve fast-growing cells and large tumor volumes, particularly Burkitt lymphoma and acute lymphoblastic leukemia. But it can also happen with newer targeted cancer drugs and antibody therapies, sometimes in cancers where it was previously rare. The surge in uric acid can trigger gout-like joint pain, and in severe cases, uric acid crystals can damage the kidneys directly. Oncologists typically anticipate this risk and use preventive strategies before starting treatment in high-risk patients.
Niacin (Vitamin B3)
High-dose niacin, sometimes prescribed for cholesterol management or taken as a supplement, can raise blood uric acid levels enough to trigger gout attacks in susceptible people. This occurs primarily with nicotinic acid, the form of niacin that causes the well-known “flushing” side effect. If you have a history of gout and are considering niacin supplements, this is worth discussing with your doctor before starting.
Gout Medications That Paradoxically Cause Flares
One of the most frustrating triggers is starting the very medications designed to treat gout long-term. Drugs like allopurinol that lower uric acid levels can actually cause more frequent flares during the first several months of treatment. This happens because when uric acid levels shift, whether up or down, it destabilizes existing uric acid crystal deposits in the joints. Crystals may partially dissolve and shed into the joint space, sparking inflammation.
This phenomenon isn’t specific to any one drug. It occurs with all urate-lowering therapies and is one of the main reasons people abandon treatment, mistakenly believing the medication isn’t working or is making things worse. To counter this, doctors typically prescribe anti-inflammatory prophylaxis for the first six months of treatment. The flares do settle down once uric acid levels have been consistently low long enough to dissolve the crystal deposits.
Choosing Safer Alternatives
If you have gout and take medications that raise uric acid, there are often alternatives. For blood pressure, losartan and calcium channel blockers both lower gout risk rather than raising it. The protective effect of losartan grows over time, cutting gout risk by 29% after two or more years of use. Calcium channel blockers show a similar pattern, with a 25% risk reduction after two years.
Not every medication swap is straightforward. Low-dose aspirin should generally be continued when needed for heart protection. Tuberculosis drugs, immunosuppressants, and chemotherapy serve critical purposes that usually outweigh the gout risk. In these situations, the strategy shifts to managing uric acid levels directly through urate-lowering therapy and having a plan in place for treating flares quickly if they occur.